16-point HLA Typing with Long Amplicon Analysis v2

Slides:



Advertisements
Similar presentations
Considerations for Analyzing Targeted NGS Data HLA
Advertisements

HLA: matching and donor selection
HLA TYPING D Middleton MDSC175: Transplantation Science for Transplant Clinicians (Online) POSTGRADUATE SCHOOL OF MEDICINE A MEMBER OF THE RUSSELL GROUP.
Introduction  Human leukocyte antigen (HLA) is the major histocompatibility complex (MHC) in humans  Group of genes ('superregion') on chromosome 6.
Center for Homogeneous DNA Analysis - Software April 21, 2005.
University of Oklahoma Genome Center4/14/12.
GENETIC FACTORS IN DIABETES MELLITUS. Birmingham Study A random sample of 4886 birth. Comparison between the most valid data: 2432North European babies.
DIABETES MELLITUS PATHOGENESIS, CLASSIFICATION, DIAGNOSIS.
HLA Genotyping Data Generated by 454 Sequencing Cherie Holcomb, Ph.D. Roche Molecular Systems picture placeholder NGS Data Consortium October 8, 2012.
HLA Analysis and Next Generation Sequencing Henry Erlich, Ph.D. Cherie Holcomb, Ph.D. Roche Molecular Systems picture placeholder NGS and EFI, May 14,
MHC and AG Presentation1 MHC and Antigen Presentation Chapters 6 & 7 Self-Test Questions: Chap 6 A: 1 – 5, 8 Note: for A-5 know MHC I - III B – D: all.
MAJOR HISTOCOMPATIBILITY COMPLEX
Organization of the MHC
Christian Gabriel, Linz
Human survivorship Developed Developing Bob May (2007), TREE 22:
An Overview of Applications for the MiSeq and HiSeq 2500 April 4, 2016 Kevin Shianna, Ph.D. Sequencing Specialist - Illumina, Inc. MGC USERS GROUP.
Validation of HLA Typing by NGS
Anajane G. Smith1, 2 Shalini E. Pereira1, 2 Dan E. Geraghty1, 2
Hong Kong Workshop Lecture 3 Antigenicity of HLA-DRDQDP Epitopes
Adaptive Immunity I.
Implementation Insights
Biology of the B Lymphocyte
New NGS products.
Introduction to GENDX HLA typing products
Chapter 7. 주조직적합성 복합체 1. 주조직적합성 복합체 (MHC)의 발견 2. MHC 분자의 구조
Causes of Variation in Substitution Rates
MAJOR HISTOCOMPATIBILITY COMPLEX
Major Histocompatibility Complex
SBT Unique Selling Points
HLA typing disease association and transplantation
DNA Analysis of the HLA Gene Complex
Major Histocompatibility complex OR
Major Histocompatibility complex OR
Major Histocompatibility complex OR
Major Histocompatibility Complex
Major Histocompatibility Complex (MHC) and its encoding molecules
Major Histocompatibility complex OR
Resolving Ambiguities
Vav‐1 gene‐targeting strategy.
بنام خداي زيبائيها.
Major Histocompatibility Complex
Performance Characteristics and Validation of Next-Generation Sequencing for Human Leucocyte Antigen Typing  Eric T. Weimer, Maureen Montgomery, Rosanne.
Jianbin Wang, H. Christina Fan, Barry Behr, Stephen R. Quake  Cell 
Richard G. Phelps, Andrew J. Rees  Kidney International 
HLA-Class I: Typing Theory
CRISPR/Cas9-mediated genome editing of PML in human cell lines.
Hou-Sung Jung, Gregory J. Tsongalis, Joel A. Lefferts 
The major histocompatibility complex (MHC) and MHC molecules
AGEseq: Analysis of Genome Editing by Sequencing
Hong Kong Workshop Lecture 4 Antigenicity of MICA epitopes
Mapping MHC-Resident Transplantation Determinants
Catherine E. Keegan, Anthony A. Killeen 
Volume 7, Issue 1, Pages (April 2014)
Supplemental Figure 3 A B C T-DNA 1 2 RGLG1 2329bp 3 T-DNA 1 2 RGLG2
Emily C. Walsh, Kristie A. Mather, Stephen F
Fine mapping the MHC region identified rs as a new variant associated with nonobstructive azoospermia in Han Chinese males  Mingtao Huang, M.D.,
The CD8α Gene Locus Is Regulated by the Ikaros Family of Proteins
Heterozygous for all alleles in MHC II
Features & Benefits GENDX SBT Products
WRKY20 dual sgRNA approach.
TS Tumor Panel (15 Genes) Overview
Human Leukocyte Antigen (HLA)
Kidney Transplantation
Illustration of the mutation and ADA2 activity.
Xiang Wan, Can Yang, Qiang Yang, Hong Xue, Xiaodan Fan, Nelson L. S
Inactivation of the Dp1 locus.
The sh339 and qmc554 alleles of gfi1b.
DQA epitope on DQA4,5,6 chains
Diagrammatic view of the locations of genes encoding classical HLA class I (HLA-A, -B, -C, -E, -F, and -G) and class II (DR, DQ, DP, and DM) molecules.
Fig. 3 Genome editing of the MSTN gene.
Presentation transcript:

16-point HLA Typing with Long Amplicon Analysis v2 Brett Bowman September 14th, 2016

What is 16-point HLA Typing? “Classical” MHC Proteins 3 CD8-presenting complexes “MHC Class I” HLA-A, B, C 1 Gene per AS 3 CD4-presenting complexes “MHC Class II” HLA-DP, DQ, DR 2 Genes Per AS 2x 1x 1x

AGENDA Long Amplicon Analysis (LAAv2) 16-point HLA Sequencing Results Overview Improvements in LAAv2 for Complex HLA Typing 16-point HLA Sequencing Results Experimental Design Typing Results Sequence Quality

Long Amplicon Analysis WorkFlow – overview Subread Filtering Coarse Clustering Waterfall Clustering Fine Phasing Consensus Post-Processing Filters Outputs Subread Filtering Coarse Clustering Waterfall Clustering Fine Phasing Consensus Post-Processing Filters Outputs Subread Filtering Coarse Clustering Waterfall Clustering Fine Phasing Consensus Post-Processing Filters Outputs Sample Locus Allele Clean-Up Report

Long Amplicon Analysis WorkFlow – Coarse & WATERFALL Clustering Subread Filtering Coarse Clustering Waterfall Clustering Fine Phasing Consensus Post-Processing Filters Outputs Filtered Subreads Clustering Subreads Waterfall Subreads Cluster #1 Cluster #2 Cluster #3

Long Amplicon Analysis WorkFlow – Fine Phasing & Consensus Subread Filtering Coarse Clustering Waterfall Clustering Fine Phasing Consensus Post-Processing Filters Outputs

Results Sample Experimental Designs & Results

What is 16-point HLA Typing? HLA Complete Panel Exon sequence only 2-step PCR 9 outer PCR ~45 inner PCR Phasing by inference 3-day turn around ~QV30 Experimental Design Re-use outer primers 3.1~5.8 kb Active-site genomic 7-loci fully phased >QV50

Long Amplicon AnALYSIS – FULL PANEL RESULTS Sequence gLen gType gPctId nMis Indel cLen cType cPctId Type Cluster0_Phase0_NumReads192 3152 A*34:01:01 100 1093 Cluster1_Phase0_NumReads194 3406 B*15:02:01 99.94 2 1045 B*15:21 Cluster2_Phase1_NumReads203 3395 B*40:01:02 Cluster2_Phase0_NumReads184 3460 C*04:03:01 1096 Cluster3_Phase1_NumReads228 3445 C*12:03:01:01 C*12:03:01 Cluster3_Phase0_NumReads215 4839 DPA1*01:03:01:04 96.88 52 601 DPA1*02:02:02 Cluster4_Phase0_NumReads234 5801 DPB1*03:01:01 99.31 39 1 657 DPB1*01:01:01 Cluster5_Phase1_NumReads178 4572 DPB1*04:02:01:02 99.47 18 6 Cluster6_Phase1_NumReads201 5743 DQA1*01:02:01:01 99.97 613 DQA1*01:02:01 Cluster5_Phase0_NumReads240 5692 DQA1*03:03:01 99.95 3 Cluster7_Phase1_NumReads236 3768 DQB1*03:05:01 99.28 19 8 618 DQB1*04:02:01 Cluster6_Phase0_NumReads216 3855 DQB1*05:01:01:01 99.52 16 DQB1*05:02:01 Cluster8_Phase1_NumReads187 5105 DRB1*04:03:01 99.05 17 31 584 DRB1*04:05:01 Cluster7_Phase0_NumReads217 3893 DRB1*15:01:01:03 DRB1*15:02:01 Sequence gLen gType gPctId nMis Indel cLen cType cPctId Type Cluster0_Phase0_NumReads195 3138 A*11:01:01:01 100 1093 A*11:01:01 Cluster1_Phase1_NumReads173 3153 A*74:02:01:02 99.84 5 A*74:01 Cluster1_Phase0_NumReads189 5778 B*07:02:01 1045 Cluster2_Phase1_NumReads179 3398 B*53:01:01 Cluster2_Phase0_NumReads212 3424 C*04:01:01:01 1096 C*04:01:01 Cluster3_Phase1_NumReads222 3429 C*07:02:01:03 C*07:02:01 Cluster4_Phase1_NumReads188 4830 DPA1*01:03:01:02 97.06 103 40 601 DPA1*02:01:01 Cluster3_Phase0_NumReads230 4857 DPA1*01:03:01:04 DPA1*01:03:01 Cluster5_Phase3_NumReads200 4574 DPB1*02:01:02 99.58 18 1 107 DPB1*01:01:01 Cluster4_Phase0_NumReads186 5800 DPB1*03:01:01 99.48 28 2 657 DPB1*107:01 Cluster5_Phase2_NumReads225 4569 DPB1*04:01:01:01 99.98 Cluster5_Phase1_NumReads220 5872 99.86 8 DPB1*04:01:01 Cluster5_Phase0_NumReads201 5751 DQA1*01:02:01:04 99.93 3 613 DQA1*01:02:01 Cluster6_Phase1_NumReads228 5691 DQA1*03:03:01 Sequence gLen gType gPctId nMis Indel cLen cType cPctId Type Cluster0_Phase0_NumReads176 3138 A*01:01:01:01 100 1093 A*01:01:01 Cluster1_Phase1_NumReads177 3152 A*02:01:01:01 A*02:01:01 Cluster1_Phase0_NumReads228 3395 B*08:01:01 1045 Cluster2_Phase1_NumReads189 B*40:01:02 Cluster2_Phase0_NumReads171 3422 C*03:04:01:01 1096 C*03:04:01 Cluster3_Phase1_NumReads200 3430 C*07:01:01:01 C*07:01:01 Cluster3_Phase0_NumReads175 4858 DPA1*01:03:01:02 602 DPA1*01:03:01 Cluster4_Phase0_NumReads193 4568 DPB1*04:01:01:01 DPB1*01:01:01 Cluster5_Phase1_NumReads210 5875 99.95 1 2 657 DPB1*04:01:01 Cluster6_Phase1_NumReads210 5691 DQA1*03:01:01 613 Cluster5_Phase0_NumReads235 5799 DQA1*05:01:01:02 610 DQA1*05:01:01 Cluster6_Phase0_NumReads239 4114 DQB1*02:01:01 99.98 618 Cluster7_Phase1_NumReads210 3775 DQB1*03:02:01 99.92 Cluster7_Phase0_NumReads175 3686 DRB1*03:01:01:01 584 DRB1*03:01:01

Long Amplicon AnALYSIS – Class I Results HLA Class I 3 genes 3.1~3.4 kb gDNA ~1.5 kb active-site 3 Sanger rxns ea ~QV30 Experimental Design 45x samples All Class I genes Complete genomic Fully phased >QV50

Introducing – Loci Analysis LociAnalysis -vv -n 16 -o OUTPUT_DIR --combineLoci DPB:DPB1:DPB2 --ignoreLoci DPB1,DPB2,H --minLengthByLocus DRB4:900 --maxLengthByLocus DRB4:2000 --maxClusteringReadsByLocus DRB1:500 --maxReadsByLocus DRB1:3000 DATABASE_FOLDER SUBREADS.BAM